Search for: "ASTRAZENECA LP" Results 121 - 140 of 159
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2010, 7:14 am by Mark Zamora
From the DOJ Press Statement:AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services’ Health Care Fraud Enforcement Action Team (HEAT) announced today. [read post]
28 Apr 2010, 7:00 am by Lucas A. Ferrara, Esq.
Cuomo today announced that New York state will receive nearly $45 million as part of a $520 million federal and multi-state settlement with AstraZeneca LP (NYSE: AZN) concerning allegations that the large pharmaceutical company provided kickbacks to doctors and engaged in an off-label marketing campaign to promote its antipsychotic drug Seroquel. [read post]
19 Mar 2010, 10:31 am by Dr. Shezad Malik
AstraZeneca Pharmaceuticals LP, MID L 1099 07 MT, Superior Court of New Jersey, Law Division, Middlesex County (New Brunswick). [read post]
10 Mar 2010, 6:05 am by John J. Cord
AstraZeneca Pharmaceuticals LP is now focusing on the drug manufacturer’s advertising strategy. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Colmetec (Olmesartan medoxomil, hydrochlorothiazide) – France: Cour d’appel de Paris say ‘non’ to olmesartan medoxomil and hydrochlorothiazide combination SPC: Daiichi Sankyo Company v INPI (SPC Blog) Crestor (Rosuvastatin) – US: Generic drug makers, Teva, Apotex and others seek to remove AstraZeneca LP as party in Crestor suit (Patent Docs) Differin (Adapalene) – US: Patent infringement complaint following a Paragraph IV… [read post]
25 Jan 2010, 5:00 am by Beck, et al.
As we said last week, because it’s a Dechert case, we can’t comment directly on Clark v. [read post]
21 Jan 2010, 1:00 am
(Patent Docs) Faslodex (Fulvestrant) - US: Infringement of US Patent following a Paragraph IV certification: AstraZeneca Pharmaceuticals LP et al. v. [read post]
8 Oct 2009, 6:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: []   Highlights this week included: Seroquel (Quetiapine) – US: CAFC: Sometimes, sins of omission are not inequitable conduct: AstraZeneca Pharmaceuticals LP v. [read post]
28 Sep 2009, 9:56 pm
Sometimes, Sins of Omission Are Not Inequitable Conduct By Kevin E. [read post]
23 Sep 2009, 10:02 pm
AstraZeneca Pharmaceuticals LP, No. 08-1056 (1st Cir. [read post]
28 Aug 2009, 8:11 am
Hewlett-Packard Company, AstraZeneca Pharmaceuticals LP, Dow Chemical Company, Advanced Micro Devices, Inc., Dreamworks Animation SKG, et al. [read post]
16 Aug 2009, 9:58 pm
Astrazeneca LP et al. v. [read post]
23 Jul 2009, 3:15 am
Astrazeneca Pharmaceuticals LP), because of Bexis' firm's involvement in the litigation (although not this aspect). [read post]